Literature DB >> 9862393

Receptor subtype specific effects of GABA agonists on neurons receiving aortic depressor nerve inputs within the nucleus of the solitary tract.

J Zhang1, S W Mifflin.   

Abstract

The inhibitory amino acid gamma amino butyrate (GABA) has been shown to profoundly alter the integration of arterial baroreceptor inputs within the nucleus of the solitary tract (NTS). However, the relative roles of the major GABA receptor subtypes, the GABA(A) and the GABA(B) receptors, in the modulation of monosynaptic compared to polysynaptic afferent transmission within the NTS remain uncharacterized. In anesthetized rats, three types of NTS neuron were identified by their responses to aortic depressor nerve (ADN) stimulation; monosynaptic neurons (MSNs), polysynaptic neurons (PSNs) and ADN non-evoked neurons (NENs). Selective GABA(A) and GABA(B) agonists were applied to these neurons using iontophoretic techniques. The endogenous ligand GABA (2 mM), the selective GABA(A) agonist muscimol (0.04 and 0.02 mM) and the GABA(B) agonist baclofen (10 mM) all inhibited the spontaneous discharge of MSNs, PSNs and NENs (P < 0.01 for each group). In addition, GABA, muscimol and baclofen also inhibited ADN evoked discharge in both MSNs and PSNs (P < 0.05 for each group). Both GABA and baclofen significantly inhibited ADN evoked discharge in PSNs to a greater extent than in MSNs (P < 0.05 for each comparison). Muscimol at both doses, however, similarly inhibited ADN evoked discharge in both MSNs and PSNs. Examination of action potential amplitude and co-iontophoretic application of glutamate and GABA agonists suggested that GABA and muscimol induced inhibition were likely to be post-synaptic in origin, while baclofen produced both pre-synaptic and post-synaptic inhibition, depending upon the cell. In conclusion, GABA can influence baroreceptor afferent integration through both pre-synaptic and post-synaptic mechanisms. Furthermore, the effects of GABA(B) agonists are variable depending upon the level of afferent integration, with MSNs being generally less sensitive than PSNs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862393     DOI: 10.1016/s0165-1838(98)00140-4

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  7 in total

1.  Mixed GABA-glycine synapses delineate a specific topography in the nucleus tractus solitarii of adult rat.

Authors:  Amandine Dufour; Fabien Tell; Jean-Pierre Kessler; Agnès Baude
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

2.  NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

3.  GABA(B)-mediated inhibition of multiple modes of glutamate release in the nucleus of the solitary tract.

Authors:  Jessica A Fawley; James H Peters; Michael C Andresen
Journal:  J Neurophysiol       Date:  2011-07-06       Impact factor: 2.714

4.  Responses of aortic depressor nerve-evoked neurones in rat nucleus of the solitary tract to changes in blood pressure.

Authors:  J Zhang; S W Mifflin
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

5.  GABA(A) receptor epsilon-subunit may confer benzodiazepine insensitivity to the caudal aspect of the nucleus tractus solitarii of the rat.

Authors:  S Kasparov; K A Davies; U A Patel; P Boscan; M Garret; J F Paton
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

6.  Hibernation induces pentobarbital insensitivity in medulla but not cortex.

Authors:  Keith B Hengen; Mary Behan; Hannah V Carey; Mathew V Jones; Stephen M Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

7.  Chronic hypertension enhances presynaptic inhibition by baclofen in the nucleus of the solitary tract.

Authors:  Weirong Zhang; Steve Mifflin
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.